Isaac Moshe

University of Helsinki | HY · Department of Psychology

Background Depression is a common comorbid condition in individuals with chronic back pain (CBP), leading to poorer treatment outcomes and increased medical complications. Digital interventions have demonstrated efficacy in the prevention and treatment of depression; however, high dropout rates are a major challenge, particularly in clinical settin...

Depression is a prevalent mental disorder. Current clinical and self-reported assessment methods of depression are laborious and incur recall bias. Their sporadic nature often misses severity fluctuations. Previous research highlights the potential of in-situ quantification of human behaviour using mobile sensors to augment traditional methods of d...

Depression is a prevalent mental disorder. Current clinical and self-reported assessment methods of depression are laborious and incur recall bias. Their sporadic nature often misses severity fluctuations. Previous research highlights the potential of in-situ quantification of human behaviour using mobile sensors to augment traditional methods of d...

The high global prevalence of depression, together with the recent acceleration of remote care owing to the COVID-19 pandemic, has prompted increased interest in the efficacy of digital interventions for the treatment of depression. We provide a summary of the latest evidence base for digital interventions in the treatment of depression based on th...

Background: Depression and anxiety are leading causes of disability worldwide but often remain undetected and untreated. Smartphone and wearable devices may offer a unique source of data to detect moment by moment changes in risk factors associated with mental disorders that overcome many of the limitations of traditional screening methods. Objecti...

Background Depression is one of the leading causes of disability worldwide. Internet- and computer-based interventions (IBIs) have been shown to provide effective, scalable forms of treatment. More than 100 controlled trials and a growing number of meta-analyses published over the past 30 years have demonstrated the efficacy of IBIs in reducing sym...